Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Price:
282.4 SEK
1.66%
Market Closed
Updated:
Jun 1, 2024
Swedish Orphan Biovitrum AB (publ)
Other Liabilities
|
Swedish Orphan Biovitrum AB (publ)
Other Liabilities Peer Comparison
Comparables:
BIOG B
HNSA
BONEX
VITR
BIOA B
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Other Liabilities
kr3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
27%
|
|
|
Biogaia AB
STO:BIOG B
|
Other Liabilities
kr91.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hansa Biopharma AB
STO:HNSA
|
Other Liabilities
kr6.8m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Other Liabilities
kr357k
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Other Liabilities
kr73m
|
CAGR 3-Years
14%
|
CAGR 5-Years
28%
|
CAGR 10-Years
12%
|
|
|
BioArctic AB
STO:BIOA B
|
Other Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Swedish Orphan Biovitrum AB (publ)'s Other Liabilities?
Other Liabilities
3B
SEK
3B
SEK
Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Other Liabilities amounts to 3B SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Other Liabilities growth rate?
Other Liabilities CAGR 10Y
27%
27%
Over the last year, the Other Liabilities growth was -30%. The average annual Other Liabilities growth rates for Swedish Orphan Biovitrum AB (publ) have been -9% over the past three years , 14% over the past five years , and 27% over the past ten years .
You don't have any saved screeners yet
